Literature DB >> 31649051

Conjunctival intraepithelial neoplasia and carcinoma: distinct clinical and histological features in relation to human papilloma virus status.

Ingvild Ramberg1,2, Peter Bjerre Toft2, Jeanette Bæhr Georgsen3, Volkert Dirk Siersma4, Mikkel Funding5, David Hebbelstrup Jensen6, Christian von Buchwald6, Steffen Heegaard7,2.   

Abstract

AIMS: Human papillomavirus (HPV) is considered a causative agent for the development of a broad range of human carcinomas. The role of HPV in the development of conjunctival intraepithelial neoplasia (CIN) and carcinoma (cSCC) remains unclear. The purpose of the present study was to investigate the HPV prevalence in a nationwide cohort and to describe clinical and histopathological features in relation to HPV status.
METHODS: All cases of CIN and cSCC in Denmark from 1980 to 2016 were included. We combined p16 immunohistochemistry (IHC), RNA in situ hybridisation (RNA ISH) and HPV DNA PCR to detect HPV. The results were correlated to clinical and histopathological parameters.
RESULTS: One hundred twelve primary tumours and 33 recurrent tumours were included for HPV analysis. Twenty-four (21%) of the primary tumours were HPV positive by PCR. Eighteen of out 19 HPV-positive tumours were positive by RNA ISH. HPV16 was the most prevalent genotype (n=18, 75%). The patients with HPV-positive tumours were significantly younger (mean difference 11.5 years, 95% CI 5.2 to 17.9, p=0.0005) and had a higher recurrence compared with patients with HPV-negative tumours (HR 2.30, 95% CI 1.02 to 5.21, p=0.046). The HPV-positive tumours were associated with a positive p16 IHC and a non-keratinising morphology.
CONCLUSION: We describe distinct clinical and histopathological features associated with HPV status in cSCC. The finding of transcriptionally active HPV in this material lends support to a causal role of HPV in a subset of cSCC. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  conjunctiva; epidemiology; infection; ocular surface; pathology

Year:  2019        PMID: 31649051     DOI: 10.1136/bjophthalmol-2019-315011

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  A case of conjunctival intraepithelial neoplasia with spheroidal degeneration: a clinicopathological study.

Authors:  Shoichiro Ota; Satoru Kase; Takayuki Tanaka; Susumu Ishida
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

2.  Detection of Human Papillomavirus in Squamous Lesions of the Conjunctiva Using RNA and DNA In-Situ Hybridization.

Authors:  Cornelia Peterson; Rupin N Parikh; Meleha T Ahmad; Ashley A Campbell; Yassine Daoud; Nicholas Mahoney; Sepideh Siadati; Charles G Eberhart
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

3.  Viral and Genomic Drivers of Squamous Cell Neoplasms Arising in the Lacrimal Drainage System.

Authors:  Ingvild Ramberg; Filipe Garrett Vieira; Peter Bjerre Toft; Christian von Buchwald; Steffen Heegaard
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

4.  Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas.

Authors:  Ingvild Ramberg; Filipe Garrett Vieira; Peter Bjerre Toft; Christian von Buchwald; Mikkel Funding; Finn Cilius Nielsen; Steffen Heegaard
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-11-01       Impact factor: 4.799

Review 5.  Human Papillomavirus Related Neoplasia of the Ocular Adnexa.

Authors:  Ingvild Ramberg; Steffen Heegaard
Journal:  Viruses       Date:  2021-08-02       Impact factor: 5.048

6.  Epstein-Barr Virus, But Not Human Papillomavirus, Is Associated With Preinvasive and Invasive Ocular Surface Squamous Neoplasias in Zambian Patients.

Authors:  Peter Julius; Stepfanie N Siyumbwa; Phyllis Moonga; Fred Maate; Trevor Kaile; Gleb Haynatski; Veenu Minhas; Jazmine Snow; Kerstin Peterson; Patience Gihozo; Sam Streeter; Salan Kaur; Annika Evans; Daniela Gonzalez; Kandali Samwel; Guobin Kang; John T West; Charles Wood; Peter C Angeletti
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.